Various theories have tried to explain the frequency and consistency of ‘hotspot’ mutations in many tumour-driving genes across different cancers. A model of the fitness benefit of these mutations shows that fundamental trade-offs occur between a tumour’s growth and its visibility to the immune system, with potential therapeutic implications.

Source link